Retail Offer Issue Price

Not for release or distribution in the United States

7 May 2025

NZX / ASX Code: EBO

RETAIL OFFER ISSUE PRICE ANNOUNCED

EBOS Group Limited’s (“EBOS”) up to A$50 million (NZ$54 million(1)) retail offer (“Retail Offer”) that was announced on Thursday, 10 April 2025 closed yesterday, Tuesday, 6 May 2025.

The new shares under the Retail Offer will be issued at the price of NZ$36.65 or A$33.92(2), which represents the lower of the price paid under the placement, the completion of which was announced on Friday, 11 April 2025, (NZ$36.65 per share) and the five-day VWAP of EBOS shares on NZX up to, and including, close of the Retail Offer.

The allotment of the new shares issued under the Retail Offer is expected to occur on Tuesday, 13 May 2025, with NZX trading in the new shares expected to commence on the same day and ASX trading in the new shares expected to commence on Wednesday, 14 May 2025. The new shares will rank equally with existing EBOS ordinary shares on issue.

A further announcement on the final outcome of the Retail Offer (including treatment of oversubscriptions, if any) is expected on Monday, 12 May 2025.

(1) Based on an A$:NZ$ exchange rate of 1.0861 as at 10 April 2025. EBOS may decide to accept applications (in whole or in part) that result in the Retail Offer raising more than A$50 million (NZ$54 million), in its absolute discretion.

(2) The A$ issue price reflects the A$:NZ$ exchange rate published by the Reserve Bank of Australia on its website at 4:00 pm AEST / 6:00pm NZST on the closing date of Tuesday, 6 May 2025, being 1.0805.

Authorised for lodgement with NZX and ASX by:
Janelle Cain
General Counsel
EBOS Group Limited
+ 61 3 9918 5555

ABOUT EBOS GROUP
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES
This market release has been prepared for publication in Australia and New Zealand and may not be released or distributed in the United States. This market release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States or any other jurisdiction in which such an offer would be illegal. The securities referred to in this release have not been, and will not be, registered under the US Securities Act of 1933 (as amended (the “US Securities Act”) or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, in the United States or to persons acting for the account or benefit of a person in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and the securities laws of any state or other jurisdiction of the United States. The securities to be offered and sold in the Retail Offer may only be offered and sold to persons that are not in the United States and are not acting for the account or benefit of a person in the United States, in each case in “offshore transactions” (as defined in Rule 902(h) under the US Securities Act) in reliance on Regulation S under the US Securities Act.
You must not send copies of this announcement or any other material relating to the Retail Offer to any person in the United States or elsewhere outside Australia and New Zealand. The release, publication or distribution of this announcement (including an electronic copy) outside New Zealand or Australia may be restricted by law. If you come into possession of this announcement, you should observe such restrictions. Any non-compliance with these restrictions may contravene applicable securities laws.

---

Announcement PDF